Elsevier

Clinical Biochemistry

Volume 20, Issue 3, June 1987, Pages 149-156
Clinical Biochemistry

Invited review
Maternal phenylketonuria (PKU) — A review

https://doi.org/10.1016/S0009-9120(87)80112-1Get rights and content

This review points out the very high incidence of damage to the fetus in untreated maternal phenylketonuria (PKU). In classical cases, 92% of the offspring are mentally retarded, 73% have microcephaly, 40% are growth retarded at birth, and 12% have congenital anomalies. Less severe types of PKU and its variants and patients treated with a low phenylalanine diet during pregnancy have a much lower incidence of these defects in their offspring. Very promising results have been obtained in a small number of preconception and early first trimester treated patients under very strict dietary control. Nutrition of the mother and fetus is a major concern during the application of this restrictive diet and must be monitored closely to avoid fetal damage from malnutrition. A 7-year collaborative study of maternal PKU began in November 1984 in the US and Canada, but even in this well publicized study, many patients are presenting late for treatment.

It is suggested that premarital and/or prenatal screening for maternal PKU should be initiated for the next generation.

References (65)

  • BuistNRM et al.

    Maternal phenylketonuria

    Lancet

    (1979)
  • FøllingA

    Uber Ausscheidung von Phenbrenztraubensaute in den Harn als Stoffwechselanomalie in verbindug mit imbezillitat

    Hoppe Seyler Z Physiol Chem

    (1934)
  • WooSLC

    Prenatal diagnosis and carrier detection of classical phenylketonuria by gene analysis

    Pediatrics

    (1984)
  • BickelH et al.

    The influence of phenylalanine intake on the chemistry and behaviour of a phenylketonuric child

    Acta Pediatr Scand

    (1954)
  • WoolfLI et al.

    Treatment of phenylketonuria with a diet low in phenylalanine

    Br Med J

    (1955)
  • GuthrieR et al.

    A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants

    Pediatrics

    (1963)
  • ScriverCR et al.

    Phenylalanine

  • YuJS et al.

    Atypical phenylketonuria. An approach to diagnosis and management

    Arch Dis Child

    (1970)
  • GuttlerF et al.

    Different phenotypes for phenylalanine hydroxylase deficiency

    Ann Clin Biochem

    (1977)
  • O'FlynnME et al.

    Hyperphenylaninemia without phenylketonuria

    Am J Dis Child

    (1967)
  • KennedyJL et al.

    The early treatment of phenylketonuria

    Am J Dis Child

    (1967)
  • BlaskovicsME et al.

    Phenylalaninaemia. Differential diagnosis

    Arch Dis Child

    (1974)
  • KochR et al.

    Phenylalaninemia and phenylketonuria

  • SmithI

    Atypical phenylketonuria accompanied by a severe progressive neurological illness unresponsive to dietary treatment

    Arch Dis Child

    (1974)
  • BartholomeK

    A new molecular defect in phenylketonuria

    Lancet

    (1974)
  • KaufmanS et al.

    Phenylketonuria due to a deficiency of dihydropteridine reductase

    N Engl J Med

    (1975)
  • KaufmanS et al.

    Tetrahydrobiopterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin

    Ann Neurol

    (1983)
  • WilliamsonML et al.

    Correlates of intelligence test results in treated phenylketonuric children

    Pediatrics

    (1981)
  • HoltzmanNA et al.

    Effect of age at loss of dietary control on intellectual performance and behavior in children with phenylketonuria

    N Engl J Med

    (1986)
  • KirkmanHN

    Projections of mental retardation from PKU

    Pediatr Res

    (1979)
  • KirkmanHN

    Projections of a rebound in frequency of mental retardation from phenylketonuria

    Appl Res Ment Retard

    (1982)
  • DentCE

    Discussion of Armstrong MD. Relation of biochemical abnormality to development of mental defect in phenylketonuria

  • Cited by (0)

    View full text